Latest GlaxoSmithKline Stories
GlaxoSmithKline said on Thursday that its cancer drug MAGE-A3 has failed its second test. The company said that the drug missed the first co-primary endpoints during the third phase of its study involving more than 2,000 lung cancer patients.
LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
The Majority of Surveyed Oncologists Have Already Prescribed Kadcyla, Just Nine Months Post-Launch, According to Findings from Decision Resources Group BURLINGTON, Mass., March 18, 2014 /PRNewswire/
On March 11, a new lawsuit was filed by an Ohio woman in Pennsylvania Eastern District Court alleging that her child suffered serious birth defects as result of her ingestion of Paxil during pregnancy.
LONDON, March 11, 2014 /PRNewswire/ -- Tungsten Corporation customers honoured for their results with electronic
Asthma Drugs Face More Scrutiny in Insurance Exchanges, According to Findings from Decision Resources Group BURLINGTON, Mass., March 5, 2014 /PRNewswire/ -- Decision Resources Group finds that
-- Advanced EPZ-5676 DOT1L inhibitor program, achieved $25 million proof of concept milestone with Celgene, and initiated Phase 1 study expansion stage for MLL-r and MLL-PTD patients CAMBRIDGE,
On January 17, a US District Court granted the motion to transfer a Paxil birth defects lawsuit to the District Court for the Southern District of Texas.
- In dressmaking, straps running from the belt in front over the shoulders to the belt in the back, with more or less elaboration of trimming and outline. They usually broaden at the shoulder and narrow toward the waist.